HOME >> MEDICINE >> NEWS
Rutgers study shows learning ability under stress still strong in Prozac-treated females

NEW BRUNSWICK/PISCATAWAY, N.J. The drug Prozac protects a female's learning abilities after a stressful or traumatic event, according to a new research study conducted at Rutgers, The State University of New Jersey.

"Depression is a devastating illness that is often accompanied in females by an inability to concentrate and learn," said Tracey J. Shors, an associate professor in the department of psychology. "Our data show that while Prozac is an effective drug for treating depression, it also protects females from the adverse effects of stress on learning."

Shors will present her findings in a paper, "Serontinergic Antidepressants Protect Females from the Adverse Effects of Stressful Experience on Learning," at the Society for Neuroscience annual meeting in Orlando, Fla., Nov. 1-6.

Shors and her research team, Benedetta Leuner, Jacqueline Falduto and Sabrina Mendolia, studied adult female rats treated with the antidepressant Prozac and a control group that received no treatment. They found that after a stressful event, learning was impaired in the control group but not in the group treated with Prozac. The researchers also found that only chronic treatment with Prozac was effective, which is consistent with reported efficacy of Prozac in patients with depression and other mental disorders.

"Importantly," Shors pointed out, "unstressed females treated with Prozac did not differ from unstressed, untreated females, indicating that Prozac itself did not affect learning."

Shors noted that males and females differ in their responses to stressful experiences. The researchers have found that exposure to a stressful experience that impairs new learning in females actually enhances new learning in males.

Since twice as many women experience depression and other stress-related mental illnesses as men, these data underscore the need to include females in research aimed at understanding the biology of mental illness, Sh
'"/>

Contact: Miguel Tersy
mtersy@ur.rutgers.edu
732-932-7084 x616
Rutgers, the State University of New Jersey
28-Oct-2002


Page: 1 2

Related medicine news :

1. Rutgers College of Nursing faculty member is funded to develop an interactive computer system
2. Rutgers-Newark researchers link early movement, brain development
3. Rutgers-developed biomaterial drives a technology transfer story toward success
4. Rutgers scientists pinpoint brain cells involved in drug addiction relapse
5. Rutgers researcher: Brains in dyslexic children can be rewired to improve reading skills
6. Rutgers wins funds to create online index of moving brain images
7. Rutgers researcher finds brain connections may reorganize in Parkinsons disease
8. Rutgers research shows caffeine may prevent skin cancer
9. Rutgers announces Robert Wood Johnson Foundation Investigator Awards in Health Policy Research
10. International Thiamine (Vitamin B-1) Conference at Rutgers Newark
11. Rutgers develops virtual reality treatment for hand impairment in chronic stroke patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/26/2017)... ... July 26, 2017 , ... Evergreen Healthcare ... of their continued efforts to provide innovative offerings to their healthcare partners. These ... and build dynamic, high-performing teams to address healthcare IT’s biggest challenges. , “Adding ...
(Date:7/26/2017)... ... 2017 , ... It's time to sign up for the new One-A-Month Essential Oil ... Heshelow, founder of Sublime Naturals and author of numerous books on essential oils. , ... by the 5th. , Two items are included in the December mailing. ...
(Date:7/26/2017)... ... July 26, 2017 , ... IDC-Eating Disorder Care is excited to ... located in Royal Oak, Michigan. IDC, formerly known as Inner Door Center, ... the highest standards in the field of eating disorder treatment in the state of ...
(Date:7/26/2017)... ... July 26, 2017 , ... The number of adults 65 years or older ... to improve asthma control in the population are not well described. In a study ... an official journal of the American Academy of Allergy, Asthma & Immunology (AAAAI), researchers ...
(Date:7/25/2017)... Raleigh, NC (PRWEB) , ... July 25, 2017 ... ... provides asset protection assistance and finance management services to communities across North Carolina, ... Bladder Cancer Advocacy Network to raise community support for the ongoing fight against ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... BEACH, Fla. , July 26, 2017 ... of enrollment of our clinical trial evaluating Altemia TM ... Cell Anemia (SCA) and Sickle Cell Disease (SCD). The ... to evaluate the efficacy and safety of Altemia TM ... trial is conducted under US IND 125274. ...
(Date:7/25/2017)... and CAMBRIDGE, Massachusetts , July ... specializing in repurposing drugs to treat rare nervous system diseases, ... to clinically develop and market the drug SOM0226 against transthyretin ... drug achieved very promising results in a Phase 2 study ... A new office in the United States ...
(Date:7/24/2017)... 2017 IBM (NYSE: IBM ) has been ... Solid-State Arrays (SSA) for the fourth year in a row. ... Gartner, "Vendors in the Leaders quadrant have the highest scores ... vendor in the Leaders quadrant has the market share, credibility, ... of new technologies. These vendors demonstrate a clear understanding of ...
Breaking Medicine Technology:
Cached News: